HOME >> BIOLOGY >> NEWS
UCLA engineers develop revolutionary nanotech water desalination membrane

Researchers at the UCLA Henry Samueli School of Engineering and Applied Science today announced they have developed a new reverse osmosis (RO) membrane that promises to reduce the cost of seawater desalination and wastewater reclamation.

Reverse osmosis desalination uses extremely high pressure to force saline or polluted waters through the pores of a semi-permeable membrane. Water molecules under pressure pass through these pores, but salt ions and other impurities cannot, resulting in highly purified water.

The new membrane, developed by civil and environmental engineering assistant professor Eric Hoek and his research team, uses a uniquely cross-linked matrix of polymers and engineered nanoparticles designed to draw in water ions but repel nearly all contaminants. These new membranes are structured at the nanoscale (the width of human hair is approximately 100,000 nanometers) to create molecular tunnels through which water flows more easily than contaminants.

Unlike the current class of commercial RO membranes, which simply filter water through a dense polymer film, Hoek's membrane contains specially synthesized nanoparticles dispersed throughout the polymer -- known as a nanocomposite material.

"The nanoparticles are designed to attract water and are highly porous, soaking up water like a sponge, while repelling dissolved salts and other impurities," Hoek said. "The water-loving nanoparticles embedded in our membrane also repel organics and bacteria, which tend to clog up conventional membranes over time."

With these improvements, less energy is needed to pump water through the membranes. Because they repel particles that might ordinarily stick to the surface, the new membranes foul more slowly than conventional ones. The result is a water purification process that is just as effective as current methods but more energy efficient and potentially much less expensive. Initial tests suggest the new
'"/>

Contact: Melissa Abraham
mabraham@support.ucla.edu
310-206-0540
University of California - Los Angeles
6-Nov-2006


Page: 1 2 3

Related biology news :

1. Boston Univeristy bioengineers devise dimmer swith to regulate gene expression in mammal cells
2. Worlds top engineers in San Antonio for system of systems conference
3. New medications, cancer diagnosis goals of UH engineers with $1M in grants
4. EO Lawrence Award goes to 8 scientists and engineers
5. Carnegie Mellon engineers devise new process to improve energy efficiency of ethanol production
6. Pittsburgh-based team engineers muscle, bone cell differentiation with aid of ink-jet printer
7. NJIT women scientists and engineers use new information technologies to tackle isolation on campus
8. MIT engineers probe spiders polymer art
9. Yale biomedical engineers receive prestigious Early Career Awards
10. Physicians and engineers pool resources to prevent stroke
11. Pitt trains budding engineers to think green

Post Your Comments:
(Date:12/19/2014)... 18, 2014   LaunchKey , the first decentralized mobile ... Internet of Things era, today announced the close of ... was led by Metamorphic Ventures with participation from ENIAC ... and others.  LaunchKey has raised $4 million to date, ...
(Date:12/17/2014)... Valencell, a leader in performance biometric data sensor ... leaders such as Intel, Jabra, Atlas, and Scosche to ... These products will be showcased at CES 2015, taking ... . "Our partners choose PerformTek biometrics, ...
(Date:12/11/2014)... and Markets , http://photos.prnewswire.com/prnh/20130307/600769 ... the addition of the "Biometrics Market in the ... One major trend emerging in this market is ... is important to upgrade biometric solutions to the latest ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
(Date:12/24/2014)... Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval application ... the use of Medtronic,s SynchroMed ® II implantable ... use with United Therapeutics, Remodulin ® (treprostinil) Injection ...
(Date:12/24/2014)...  Vermillion, Inc. (Nasdaq:   VRML), a bio-analytical solutions ... the Company closed its previously announced private placement ... W. Schuler , Birchview Fund LLC and several ... offering expenses.  The proceeds will be used for ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 “Preparative ... Gas, HPLC, Flash), Consumables (Columns, Solvents, Buffers, Valves, ... Food & Agriculture) - Forecasts to 2019” provides ... challenges, opportunities, current market trends, and strategies impacting ...
(Date:12/24/2014)... Earlier this year in a June 24 international conference presentation, ... Technology Center, LLC ( ASCTC ) focused attention on an ... stem cells. His title “Asymmetric Self-Renewal by Distributed Stem ... the essence of his message to congress participants. He ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
Cached News: